| Grant H Louie, MD | |
|
2730 University Blvd W Ste 310, Wheaton, MD 20902-1990 | |
| (301) 942-7600 | |
| (301) 942-3132 |
| Full Name | Grant H Louie |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 23 Years |
| Location | 2730 University Blvd W Ste 310, Wheaton, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306013214 | NPI | - | NPPES |
| 036428200 | Medicaid | MD |
| Facility Name | Location | Facility Type |
|---|---|---|
| Frederick Health Hospital | Frederick, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arthritis And Rheumatism Associates Pc | 5597750703 | 49 |
| Arthritis And Rheumatism Associates Pc | 5597750703 | 49 |
| Amber Hill Physical Therapy Inc | 8527963917 | 67 |
News Archive
A child's home address may be enough information to identify children and families at risk for more severe cases of asthma due to social and economic hardships. In fact, the home address could guide risk assessment starting the moment a family arrives and registers in the hospital or at the doctor's office.
Every once in a while a politician comes up with an idea that's so bad, so wrongheaded, that you're almost grateful. For really bad ideas can help illustrate the extent to which policy discourse has gone off the rails. And so it was with Senator Joseph Lieberman's proposal, released last week, to raise the age for Medicare eligibility from 65 to 67.
London Genetics Limited, an expert in the use of pharmacogenetics in clinical drug discovery and development, is pleased to announce that its third annual pharmacogenetic conference will feature top-level presentations from players in all parts of the healthcare chain.
The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.
› Verified 2 days ago
| Entity Name | Arthritis And Rheumatism Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447259866 PECOS PAC ID: 5597750703 Enrollment ID: O20180307000450 |
News Archive
A child's home address may be enough information to identify children and families at risk for more severe cases of asthma due to social and economic hardships. In fact, the home address could guide risk assessment starting the moment a family arrives and registers in the hospital or at the doctor's office.
Every once in a while a politician comes up with an idea that's so bad, so wrongheaded, that you're almost grateful. For really bad ideas can help illustrate the extent to which policy discourse has gone off the rails. And so it was with Senator Joseph Lieberman's proposal, released last week, to raise the age for Medicare eligibility from 65 to 67.
London Genetics Limited, an expert in the use of pharmacogenetics in clinical drug discovery and development, is pleased to announce that its third annual pharmacogenetic conference will feature top-level presentations from players in all parts of the healthcare chain.
The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Grant H Louie, MD 2730 University Blvd W Ste 310, Wheaton, MD 20902-1990 Ph: (301) 942-7600 | Grant H Louie, MD 2730 University Blvd W Ste 310, Wheaton, MD 20902-1990 Ph: (301) 942-7600 |
News Archive
A child's home address may be enough information to identify children and families at risk for more severe cases of asthma due to social and economic hardships. In fact, the home address could guide risk assessment starting the moment a family arrives and registers in the hospital or at the doctor's office.
Every once in a while a politician comes up with an idea that's so bad, so wrongheaded, that you're almost grateful. For really bad ideas can help illustrate the extent to which policy discourse has gone off the rails. And so it was with Senator Joseph Lieberman's proposal, released last week, to raise the age for Medicare eligibility from 65 to 67.
London Genetics Limited, an expert in the use of pharmacogenetics in clinical drug discovery and development, is pleased to announce that its third annual pharmacogenetic conference will feature top-level presentations from players in all parts of the healthcare chain.
The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.
› Verified 2 days ago
Alan Ken Matsumoto, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2730 University Blvd W, Suite 310, Wheaton, MD 20902 Phone: 301-942-7600 Fax: 301-942-3132 | |
Dr. Herbert Stuart Block Baraf, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2730 University Blvd W, Suite 310, Wheaton, MD 20902 Phone: 301-942-7600 Fax: 301-942-3132 | |
Barry I Hecht, M.D. Rheumatology Medicare: Medicare Enrolled Practice Location: 3941 Ferrara Dr, Wheaton, MD 20906 Phone: 301-942-5355 | |
Dr. Nicole Marie Saddic Thomas, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2730 University Blvd W, 310, Wheaton, MD 20902 Phone: 301-942-7600 Fax: 301-942-3132 | |
Dr. Peter Bruce Sherer, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 3921 Ferrara Dr, Wheaton, MD 20906 Phone: 301-946-6420 Fax: 301-946-0642 | |
Dr. Mark K Li, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1721 University Blvd W, Wheaton, MD 20902 Phone: 301-649-5151 Fax: 301-649-7368 |